Development of New Drugs

29 new medicines (NCE) and more than 82 Incrementally Modified Drugs(IMD)

As of 2017, Korea has succeeded in developing 29 new medicines since the inception of Sunpla Injection (SK Chemicals) in 1999, an anti-cancer medicine and Korea’s very first locally developed new medicine. Korea also developed 82 incrementally modified drugs by the end of 2016. Of the 29 new medicines, a total of 8 new drugs have been approved by the US FDA and 9 new drugs have also been approved by EMA as of March, 2018.